[144] Corning Incorporated SEC Filing
Rhea-AI Filing Summary
This Form 144 records a proposed sale of 20,000 common shares to be executed through UBS Financial Services on 09/04/2025, with an aggregate market value of $1,404,579.53. The filing reports 856,618,711 shares outstanding. It lists the seller's recent dispositions: sales of 18,850 shares on 08/12/2025 for $1,231,158, 20,000 shares on 08/07/2025 for $1,317,550, and 20,000 shares on 05/27/2025 for $1,022,259, each attributed to Eric Musser at an address in Corning, NY. The document also details the acquisition history for the securities sold, showing multiple restricted and performance stock releases between 04/15/2021 and 08/08/2024. By signing, the seller represents no knowledge of undisclosed material adverse information.
Positive
- Rule 144 compliance documented with broker details, planned sale date, and aggregate market value disclosed
- Detailed acquisition history (dates and types of restricted/performance stock releases) aids transparency
- Recent sale transactions disclosed with dates, amounts, and gross proceeds attributed to the seller
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice showing ongoing insider sales; quantities are small relative to total shares outstanding.
The filing documents a proposed sale of 20,000 common shares via UBS and discloses three recent sales by the same person totaling 58,850 shares in the past three months. The filing provides acquisition dates and types (restricted/performance stock releases), which helps trace holding periods relevant to Rule 144 compliance. No financial results, company disclosures, or new material events are included in the form itself, limiting investor inference to trading activity only.
TL;DR: Filing is a standard compliance disclosure; it confirms the insider attestation about material nonpublic information.
The notice fulfills procedural requirements by naming the broker, listing shares to be sold, and providing the seller's recent sales and acquisition history. The signed representation that the seller lacks undisclosed material adverse information is standard language and important for 10b5-1/RULE 144 context. The form does not indicate any governance actions or changes to executive roles.